1. Home
  2. XENE vs UE Comparison

XENE vs UE Comparison

Compare XENE & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • UE
  • Stock Information
  • Founded
  • XENE 1996
  • UE 2014
  • Country
  • XENE Canada
  • UE United States
  • Employees
  • XENE N/A
  • UE N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • UE Real Estate
  • Sector
  • XENE Health Care
  • UE Finance
  • Exchange
  • XENE Nasdaq
  • UE Nasdaq
  • Market Cap
  • XENE 2.5B
  • UE 2.2B
  • IPO Year
  • XENE 2014
  • UE N/A
  • Fundamental
  • Price
  • XENE $28.85
  • UE $18.13
  • Analyst Decision
  • XENE Strong Buy
  • UE Hold
  • Analyst Count
  • XENE 11
  • UE 1
  • Target Price
  • XENE $54.82
  • UE $22.00
  • AVG Volume (30 Days)
  • XENE 1.5M
  • UE 746.1K
  • Earning Date
  • XENE 05-12-2025
  • UE 04-30-2025
  • Dividend Yield
  • XENE N/A
  • UE 4.18%
  • EPS Growth
  • XENE N/A
  • UE N/A
  • EPS
  • XENE N/A
  • UE 0.63
  • Revenue
  • XENE $7,500,000.00
  • UE $453,505,000.00
  • Revenue This Year
  • XENE N/A
  • UE $6.42
  • Revenue Next Year
  • XENE $611.23
  • UE $4.60
  • P/E Ratio
  • XENE N/A
  • UE $28.65
  • Revenue Growth
  • XENE N/A
  • UE 8.73
  • 52 Week Low
  • XENE $26.74
  • UE $15.66
  • 52 Week High
  • XENE $46.00
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • XENE 34.31
  • UE 47.91
  • Support Level
  • XENE $29.38
  • UE $17.46
  • Resistance Level
  • XENE $31.74
  • UE $18.33
  • Average True Range (ATR)
  • XENE 1.34
  • UE 0.36
  • MACD
  • XENE -0.31
  • UE -0.03
  • Stochastic Oscillator
  • XENE 7.53
  • UE 37.02

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: